This brand name is authorized in Estonia, Ireland, Malta, United Kingdom
The drug VOLTAROL contains one active pharmaceutical ingredient (API):
|
1
Diclofenac
UNII QTG126297Q - DICLOFENAC SODIUM
|
|
Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| VOLTAROL Medicated Plaster | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| VOLTAROL PAIN-EZE EMULGEL Gel for topical administration | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| VOLTAROL OPTHA MULTIDOSE Eye drops solution | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| VOLTAROL RAPID Coated tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| VOLTAROL Suppositories | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| M01AB05 | Diclofenac | M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AB Acetic acid derivatives and related substances |
| M02AA15 | Diclofenac | M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain → M02AA Antiinflammatory preparations, non-steroids for topical use |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1593604, 1628973, 1671094, 1686810, 1779497 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 117823, 138336, 139787, 147602, 147607, 147614, 147616, 155254, 164472, 164474, 164476, 166817, 176269, 182070, 224797, 224799, 239561, 239567, 25815, 263526, 26389, 26390, 26835, 27303, 28938, 28941, 302469, 302470, 38352, 38355, 391374, 46375, 91000 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 52372, 52431, 52434, 55261, 55279, 77443 |
| Country: MT | Medicines Authority | Identifier(s): AA908/10102 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
